Bandaram Pharma Packtech Limited (BOM:524602)
India · Delayed Price · Currency is INR 34.76
-1.82 (-4.98%)
At close: Dec 5, 2025
Bandaram Pharma Packtech Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 403.18 | 369.64 | 340.79 | 187.32 | - | - | Upgrade |
Other Revenue | 0 | 0 | 0 | - | - | - | Upgrade |
| 403.18 | 369.64 | 340.79 | 187.32 | - | - | Upgrade | |
Revenue Growth (YoY) | 13.29% | 8.46% | 81.93% | - | - | - | Upgrade |
Cost of Revenue | 336.64 | 296.5 | 275.54 | 160.48 | - | - | Upgrade |
Gross Profit | 66.53 | 73.14 | 65.25 | 26.84 | - | - | Upgrade |
Selling, General & Admin | 31.93 | 33.96 | 30.43 | 7.96 | - | - | Upgrade |
Other Operating Expenses | 10.75 | 10.02 | 6.35 | 5.51 | 0.1 | 0.13 | Upgrade |
Operating Expenses | 48.48 | 50.11 | 44.06 | 19.32 | 0.1 | 0.32 | Upgrade |
Operating Income | 18.06 | 23.03 | 21.19 | 7.52 | -0.1 | -0.32 | Upgrade |
Interest Expense | -10.48 | -8.08 | -6.14 | -3.45 | -0 | - | Upgrade |
Interest & Investment Income | - | - | 0.02 | 0.03 | - | - | Upgrade |
Currency Exchange Gain (Loss) | - | - | - | 0.03 | - | - | Upgrade |
Other Non Operating Income (Expenses) | -1.79 | -1.79 | -3.2 | -0.87 | - | - | Upgrade |
EBT Excluding Unusual Items | 5.79 | 13.16 | 11.87 | 3.26 | -0.1 | -0.32 | Upgrade |
Pretax Income | 5.79 | 13.16 | 11.87 | 3.26 | -0.1 | -0.32 | Upgrade |
Income Tax Expense | 3.22 | 3.22 | 2.39 | 0.68 | - | - | Upgrade |
Net Income | 5.88 | 9.94 | 9.48 | 2.58 | -0.1 | -0.32 | Upgrade |
Net Income to Common | 5.88 | 9.94 | 9.48 | 2.58 | -0.1 | -0.32 | Upgrade |
Net Income Growth | -63.33% | 4.86% | 268.04% | - | - | - | Upgrade |
Shares Outstanding (Basic) | 12 | 12 | 12 | 3 | 3 | 2 | Upgrade |
Shares Outstanding (Diluted) | 12 | 12 | 12 | 3 | 3 | 2 | Upgrade |
Shares Change (YoY) | - | - | 300.00% | - | 31.75% | 900.15% | Upgrade |
EPS (Basic) | 0.48 | 0.83 | 0.79 | 0.86 | -0.03 | -0.14 | Upgrade |
EPS (Diluted) | 0.48 | 0.83 | 0.79 | 0.86 | -0.03 | -0.14 | Upgrade |
EPS Growth | - | 4.86% | -7.99% | - | - | - | Upgrade |
Free Cash Flow | -21.73 | -50.12 | -43.09 | -38.94 | 29.15 | - | Upgrade |
Free Cash Flow Per Share | -1.78 | -4.18 | -3.59 | -12.98 | 9.72 | - | Upgrade |
Dividend Per Share | 0.100 | 0.100 | 0.100 | 0.100 | - | - | Upgrade |
Gross Margin | 16.50% | 19.79% | 19.15% | 14.33% | - | - | Upgrade |
Operating Margin | 4.48% | 6.23% | 6.22% | 4.01% | - | - | Upgrade |
Profit Margin | 1.46% | 2.69% | 2.78% | 1.38% | - | - | Upgrade |
Free Cash Flow Margin | -5.39% | -13.56% | -12.64% | -20.79% | - | - | Upgrade |
EBITDA | 23.85 | 29.16 | 28.33 | 13.32 | 0.08 | -0.13 | Upgrade |
EBITDA Margin | 5.92% | 7.89% | 8.31% | 7.11% | - | - | Upgrade |
D&A For EBITDA | 5.8 | 6.13 | 7.14 | 5.8 | 0.18 | 0.18 | Upgrade |
EBIT | 18.06 | 23.03 | 21.19 | 7.52 | -0.1 | -0.32 | Upgrade |
EBIT Margin | 4.48% | 6.23% | 6.22% | 4.01% | - | - | Upgrade |
Effective Tax Rate | 55.66% | 24.48% | 20.13% | 20.91% | - | - | Upgrade |
Revenue as Reported | 404.2 | 370.58 | 341.12 | 189.22 | - | - | Upgrade |
Advertising Expenses | - | 0.24 | 0.15 | 0.37 | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.